NOMA:NASDAQNOMADAR Corp. Analysis
Data as of 2026-05-30 - not real-time
$3.50
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Nomadar Corp. is trading at $3.50, marginally above its 20‑day SMA (3.47) but well below the 50‑day (3.77) and 200‑day (5.06) averages, confirming a bearish price trend despite a modest bullish signal from the MACD histogram. The stock exhibits extreme short‑term volatility (103% 30‑day) and a massive historical drawdown of –73.7%, while its systematic risk is low (beta ≈ 0.10). Fundamentally, the company is severely overvalued – PB of 5.0, price‑to‑sales of 53.4, negative operating margin (‑1.87%) and a net‑debt position of $1.66 M, yielding a DCF fair value near zero.
A recent strategic framework agreement with Fox Soccer Academy could provide a growth catalyst in the youth‑soccer segment, yet the current financial profile – negative earnings, negative cash flow, and high debt‑to‑equity (≈31) – limits upside. The market sentiment is at an “Extreme Greed” level (94.07), suggesting price pressure may be driven more by speculation than fundamentals.
A recent strategic framework agreement with Fox Soccer Academy could provide a growth catalyst in the youth‑soccer segment, yet the current financial profile – negative earnings, negative cash flow, and high debt‑to‑equity (≈31) – limits upside. The market sentiment is at an “Extreme Greed” level (94.07), suggesting price pressure may be driven more by speculation than fundamentals.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- price near short‑term support but below medium‑term averages
- extreme volatility and recent large drawdown
- strategic partnership offering potential near‑term upside
Medium Term
1–3 yearsNeutral
Model confidence: 4/10
Key Factors
- persistent negative earnings and cash flow
- high valuation multiples relative to book and sales
- uncertain monetization of new soccer‑tech initiatives
Long Term
> 3 yearsCautious
Model confidence: 3/10
Key Factors
- structural overvaluation and weak profitability
- significant net‑debt burden and high debt‑to‑equity ratio
- lack of dividend and limited cash‑generation capacity
Key Metrics & Analysis
Financial Health
Revenue Growth116.00%
ROE-80.79%
ROA-20.90%
Debt/Equity30.92
P/B Ratio5.0
Op. Cash Flow$-1165777
Free Cash Flow$46.2K
Technical Analysis
TrendBearish
RSI48.5
Support$2.55
Resistance$4.00
MA 20$3.47
MA 50$3.77
MA 200$5.06
MACDBullish
VolumeIncreasing
Fear & Greed Index94.07
Valuation
Fair Value$0.00
GradeOvervalued
TypeValue
Risk Assessment
Beta0.10
Volatility103.61%
Sector RiskHigh
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.